Cardiovascular Systems Inc. (CSII)

34.19
0.59 1.76
NASDAQ : Health Technology
Prev Close 33.60
Open 33.41
Day Low/High 33.09 / 34.23
52 Wk Low/High 20.89 / 40.00
Volume 474.64K
Avg Volume 236.80K
Exchange NASDAQ
Shares Outstanding 34.82M
Market Cap 1.17B
EPS 0.10
P/E Ratio 672.00
Div & Yield N.A. (N.A)

Latest News

First Patients In The Middle East Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

First Patients In The Middle East Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in...

Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues Of $60.2 Million

Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues Of $60.2 Million

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced preliminary and unaudited...

Cardiovascular Systems, Inc. Receives Approval For The Diamondback 360® Coronary Orbital Atherectomy System With Classic Crown And New ViperWire Advance® FlexTip Guidewire In Japan

Cardiovascular Systems, Inc. Receives Approval For The Diamondback 360® Coronary Orbital Atherectomy System With Classic Crown And New ViperWire Advance® FlexTip Guidewire In Japan

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that Japan's Ministry of...

Cardiovascular Systems, Inc. Announces First Patients Treated In United States With OrbusNeich Teleport® Microcatheter

Cardiovascular Systems, Inc. Announces First Patients Treated In United States With OrbusNeich Teleport® Microcatheter

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the first patients in...

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

CSII: Insiders Vs. Shorts

CSII: Insiders Vs. Shorts

The most recent short interest data was recently released for the 11/30/2018 settlement date, and Cardiovascular Systems, Inc is one of the most shorted stocks of the Russell 3000, based on 6.58 "days to cover" versus the median component at 5.06. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

First Patients In Europe Treated With Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System

First Patients In Europe Treated With Cardiovascular Systems, Inc. Peripheral Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in...

First Patient In Hong Kong Treated With Cardiovascular Systems, Inc. Coronary Orbital Atherectomy System

First Patient In Hong Kong Treated With Cardiovascular Systems, Inc. Coronary Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in...

Cardiovascular Systems, Inc. Reports Fiscal 2019 First-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2019 First-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal first...

Cardiovascular Systems, Inc. To Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30

Cardiovascular Systems, Inc. To Webcast Fiscal 2019 First-Quarter Earnings Conference Call Tuesday, October 30

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII) will host a live webcast of its fiscal 2019 first-quarter conference call on Tuesday, October 30, 2019, at 3:45 p.

Cardiovascular Systems, Inc. Announces First Commercial Launch Of Peripheral Orbital Atherectomy System Outside The United States

Cardiovascular Systems, Inc. Announces First Commercial Launch Of Peripheral Orbital Atherectomy System Outside The United States

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in...

Cardiovascular Systems Presents Liberty 360° Two-Year Outcomes At 2018 Amputation Prevention Symposium

Cardiovascular Systems Presents Liberty 360° Two-Year Outcomes At 2018 Amputation Prevention Symposium

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, presented two-year outcomes from its...

Cardiovascular Systems, Inc. And Aerolase Corp. Sign Collaborative Agreement For Laser Atherectomy Technology

Cardiovascular Systems, Inc. And Aerolase Corp. Sign Collaborative Agreement For Laser Atherectomy Technology

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that it has signed an...

Cardiovascular Systems, Inc. Reports Fiscal 2018 Fourth-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2018 Fourth-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal fourth...

Cardiovascular Systems, Inc. Signs International Distribution Agreement With OrbusNeich

Cardiovascular Systems, Inc. Signs International Distribution Agreement With OrbusNeich

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral Orbital Atherectomy Systems (OAS) outside the United States and Japan.

Cardiovascular Systems, Inc. To Release Fiscal 2018 Fourth-Quarter Results On July 30

Cardiovascular Systems, Inc. To Release Fiscal 2018 Fourth-Quarter Results On July 30

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII) will release fourth-quarter results on July 30 after market close.

Cardiovascular Systems, Inc. Reports Fiscal 2018 Third-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2018 Third-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial results for its fiscal third...

Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes At CRT18 Interventional Cardiology Conference

Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes At CRT18 Interventional Cardiology Conference

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease,...

Cardiovascular Systems, Inc. And OrbusNeich Announce FDA Clearance Of The First And Only 1.0mm Coronary Balloon In The U.S.

Cardiovascular Systems, Inc. And OrbusNeich Announce FDA Clearance Of The First And Only 1.0mm Coronary Balloon In The U.S.

Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today...

Cardiovascular Systems Becomes Oversold (CSII)

Cardiovascular Systems Becomes Oversold (CSII)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cardiovascular Systems, Inc. Announces First Patients Treated From Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device

Cardiovascular Systems, Inc. Announces First Patients Treated From Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device

Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, announced today...

Cardiovascular Systems, Inc. Appoints Jeff Points As Chief Financial Officer

Cardiovascular Systems, Inc. Appoints Jeff Points As Chief Financial Officer

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that Jeff Points was named Chief Financial Officer (CFO), effective immediately.

Cardiovascular Systems, Inc. Reports Fiscal 2018 Second-Quarter Financial Results

Cardiovascular Systems, Inc. Reports Fiscal 2018 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today reported financial...

Cardiovascular Systems, Inc. To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

Cardiovascular Systems, Inc. To Present At The LEERINK Partners 7th Annual Global Healthcare Conference

On Wednesday, February 14, 2018, Cardiovascular Systems' (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the LEERINK Partners 7 th Annual Global Healthcare Conference at 10:30 a.

Cardiovascular Systems, Inc. Announces Commercial Launch In Japan

Cardiovascular Systems, Inc. Announces Commercial Launch In Japan

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced...

Noteworthy Wednesday Option Activity: CSII, GME, ACAD

Noteworthy Wednesday Option Activity: CSII, GME, ACAD

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cardiovascular Systems, Inc , where a total volume of 1,104 contracts has been traded thus far today, a contract volume which is representative of approximately 110,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 50.9% of CSII's average daily trading volume over the past month, of 217,075 shares.

Cardiovascular Systems, Inc. Appoints Rhonda Robb As New Chief Operating Officer

Cardiovascular Systems, Inc. Appoints Rhonda Robb As New Chief Operating Officer

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today announced that it has...

First Week of CSII February 16th Options Trading

First Week of CSII February 16th Options Trading

Investors in Cardiovascular Systems, Inc saw new options begin trading this week, for the February 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CSII options chain for the new February 16th contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: C- (Hold)